Status:
COMPLETED
Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Pre Diabetes
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engage...
Detailed Description
Using a mixed-methods design, this study will be completed in three phases. For Phase 3, we aim to conduct a randomized control trial with 400 patients with pre-diabetic, all of whom will be using the...
Eligibility Criteria
Inclusion
- 18 years or older, BMI ≥ 25 kg/m2 (\> 22 kg/m2 if self-identified as Asian)
- Must be a NYU Langone patient
- A diagnosis of prediabetes (either diagnosis of prediabetes or an HbA1C level of 5.7%-6.4% in past 12 months) or diabetes risk factors (BMI ≥ 25 kg/m2 or \> 22 kg/m2 if self-identified as Asian
- Safe to engage in moderate physical exercise (as determined by their PCP)
- Sufficient English to be able to complete the enrollment process
- Has app-capable device with data to use the dDPP application and receive text messages
Exclusion
- Diagnosed with diabetes
- Patients whose weight may vary considerably over the study's timeframe for reasons other than the intervention (e.g. cancer, pregnancy, ascites, severe CHF)
- Patients with severe psychiatric disease or dementia
- Active health condition that prevents them from engaging in moderate exercise
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
551 Patients enrolled
Trial Details
Trial ID
NCT04773834
Start Date
February 1 2021
End Date
June 1 2025
Last Update
October 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016